数字乳腺断层合成与合成二维乳腺摄影对比数字乳腺摄影:在人群筛查项目中的评估
这项前瞻性队列研究纳入人群筛查项目中2014至2015年接受数字乳腺断层合成联合合成二维乳腺摄影筛查的37185名女性和接受数字乳腺摄影筛查的61742名女性,比较召回率、筛查检出乳腺癌率及肿瘤病理特征等早期性能指标。结果显示两种筛查方式的召回率无显著差异(3.4% vs 3.3%,P=.563),但数字乳腺断层合成联合合成二维乳腺摄影的筛查检出癌率更高(每1000名筛查者9.4 vs 6.1,P<.001),且检出≤10 mm肿瘤和1级肿瘤的率均更高。
要点
- 数字乳腺断层合成联合合成二维乳腺摄影筛查的召回率为3.4%,数字乳腺摄影为3.3%,两者无显著差异(P=.563)。
- 数字乳腺断层合成联合合成二维乳腺摄影的筛查检出癌率为每1000名筛查者9.4例,数字乳腺摄影为6.1例(P<.001)。
- 数字乳腺断层合成联合合成二维乳腺摄影检出≤10 mm肿瘤和1级肿瘤的率均高于数字乳腺摄影(P<.001)。
核心结论
- 数字乳腺断层合成联合合成二维乳腺摄影筛查相比数字乳腺摄影提高了组织学有利肿瘤的检出率。
研究设计与样本
- 前瞻性队列研究,纳入人群筛查项目中2014至2015年接受数字乳腺断层合成联合合成二维乳腺摄影筛查的37185名女性和接受数字乳腺摄影筛查的61742名女性,比较早期性能指标。
诊断标准与关键数值
- 召回率:数字乳腺断层合成联合合成二维乳腺摄影3.4%,数字乳腺摄影3.3%(P=.563)。
- 筛查检出癌率:数字乳腺断层合成联合合成二维乳腺摄影每1000名筛查者9.4例,数字乳腺摄影每1000名筛查者6.1例(P<.001)。
- ≤10 mm肿瘤检出率:数字乳腺断层合成联合合成二维乳腺摄影每1000名筛查者3.2例,数字乳腺摄影每1000名筛查者1.8例(P<.001)。
- 1级肿瘤检出率:数字乳腺断层合成联合合成二维乳腺摄影每1000名筛查者3.3例,数字乳腺摄影每1000名筛查者1.4例(P<.001)。
- 淋巴结受累率和肿瘤亚型在两种筛查方式间无差异。
临床应用与阅片要点
- 数字乳腺断层合成联合合成二维乳腺摄影可在不增加召回率的情况下提高筛查检出癌率。
- 数字乳腺断层合成联合合成二维乳腺摄影对≤10 mm肿瘤和1级肿瘤的检出率高于数字乳腺摄影。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To compare the performance of digital breast tomosynthesis (DBT) and two-dimensional synthetic mammography (SM) with that of digital mammography (DM) in a population-based mammographic screening program. Materials and Methods In this prospective cohort study, data from 37 185 women screened with DBT and SM and from 61 742 women screened with DM as part of a population-based screening program in 2014 and 2015 were included. Early performance measures, including recall rate due to abnormal mammographic findings, rate of screen-detected breast cancer, positive predictive value of recall, positive predictive value of needle biopsy, histopathologic type, tumor size, tumor grade, lymph node involvement, hormonal status, Ki-67 level, and human epidermal growth factor receptor 2 status were compared in women who underwent DBT and SM screening and in those who underwent DM screening by using χ2 tests, two-sample unpaired t tests, and tests of proportions. Results Recall rates were 3.4% for DBT and SM screening and 3.3% for DM screening (P = .563). DBT and SM screening showed a significantly higher rate of screen-detected cancer compared with DM screening (9.4 vs 6.1 cancers per 1000 patients screened, respectively; P < .001). The rate of detection of tumors 10 mm or smaller was 3.2 per 1000 patients screened with DBT and SM and 1.8 per 1000 patients screened with DM (P < .001), and the rate of grade 1 tumors was 3.3 per 1000 patients screened with DBT and SM versus 1.4 per 1000 patients screened with DM (P < .001). On the basis of immunohistochemical analyses, rates of lymph node involvement and tumor subtypes did not differ between women who underwent DBT and SM screening and those who underwent DM screening. Conclusion DBT and SM screening increased the detection rate of histologically favorable tumors compared with that attained with DM screening. © RSNA, 2018 Online supplemental material is available for this article.
引用
- Hofvind S, Hovda T, Holen ÅS, et al. Digital Breast Tomosynthesis and Synthetic 2D Mammography versus Digital Mammography: Evaluation in a Population-based Screening Program. Radiology. 2018. PMID: 29494322. doi:10.1148/radiol.2018171361
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。